BioCellChallenge obtains unprecedented in-vivo results using intracellular delivery technology for therapeutic antibodies
11/30/2015

For the first time, in-vivo tests have shown that an anti-Ras antibody combined with ImmunoCellin technology slows tumor growth in all cases and leads to full recovery in one-third of cases.

Many Europeans still exposed to harmful air pollution
11/30/2015

Air pollution is the single largest environmental health risk in Europe. It shortens people's lifespan and contributes to serious illnesses such as heart disease, respiratory problems and cancer.

Medicaid expansion improves breast cancer screening for low-income women
11/30/2015

Low-income women in Medicaid expansion states in the U.S. are more likely to have a breast screening performed than those in non-expansion states, according to a study presented today at the annual...

Sobi and Biogen's Elocta (rFVIIIFc) approved in Europe for the treatment of haemophilia A
11/27/2015

Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) and Biogen (NASDAQ: BIIB) have announced that the European Commission (EC) has approved Elocta® (rFVIIIFc) for the treatment of haemophilia...

Novartis launch drug for rare lung cancer subtype but patients in England may be denied access
11/26/2015

Novartis announced today that the new advanced lung cancer medicine, Zykadia® (ceritinib), is now launched and available in the UK, however the recent negative draft decision from the National...

Study finds complete remission rates for almost all late-stage cancer types, regardless of treatment, are equally low
11/26/2015

Complete Responses (CRs) are dramatic, highly desirable situations for patients where all cancer disappears.

Promising drug combination for advanced prostate cancer
11/26/2015

A new drug combination may be effective in treating men with metastatic prostate cancer.

Population Council's MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study
11/26/2015

MZC microbicide gel demonstrates strong efficacy against HIV and HSV-2 in preclinical study.

Data scientists create world's first therapeutic venom database
11/26/2015

Open-source library describes nearly 43,000 effects on the human body.What doesn't kill you could cure you.

Scientists map genes essential for cancer to survive
11/26/2015

Using new technology, scientists have mapped thousands of genes that are essential for cancer cell survival, and have started to identify clusters unique to individual cancers.